Active Mental Health Pregnancy, Children & Inherited Conditions

What is the molecular genetic basis of anxiety in a very-low-income African setting? The Genetics of Anxiety In Malawi (G-AIM) Study.

In plain English

AI plain-English summary

The first large-scale genetic study of anxiety in an African population is now underway in Malawi, linking DNA analysis to the lived experience of severe anxiety in communities facing poverty, food insecurity, and unstable housing. Anxiety disorders are among the most common mental health conditions worldwide, but nearly all genetic research has been done in people of European ancestry. This leaves a critical gap: the genetic architecture of anxiety in African populations—who carry the greatest genetic diversity on the planet—remains unknown. Without this knowledge, treatments and risk predictions developed elsewhere may not work for these populations. The study also addresses a deeper problem: how severe anxiety affects daily life and livelihoods in settings where multiple insecurities compound one another. If successful, this research could reveal specific genetic variants and molecular mechanisms driving anxiety in this context. That would lay the groundwork for precision medicine approaches—targeted prevention and treatment tailored to individuals based on their genetic risk. It would also build genomics and metabolomics capacity within Malawi, ensuring that future discoveries include people of African ancestry rather than excluding them.

View original technical description
Building on an existing longitudinal mental health resource in rural and urban Malawi, we will bring together national and international expertise to conduct the first large genetic association analysis of a broad anxiety measure in an African population. We will link this work to a new understanding of the lived experience of severe anxiety in highly vulnerable populations, exposed to multiple insecurities and set the foundations for a precision medicine approach to prevent and treat anxiety. We seek to (1) identify the impact of anxiety on lives and livelihoods (2) identify the correlates, antecedents and consequences of anxiety using traditional epidemiological approaches (3) understand the genetic architecture, and molecular mechanisms of anxiety, (4) identify the risk signatures in young children and adults to signpost possible disease mechanisms and for risk stratification. We will conduct repeat measures of generalised anxiety disorder and conduct qualitative research in key age groups in both rural and urban populations and work with experts in the fields of genomics and metabolomics research to build capacity in these disciplines within Malawi. We will explore the potential and acceptability of industry partnerships to ensure that future discovery using these tools includes those of African ancestry.

View the original record at the funder ↗

Researchers

Amelia Crampin (EPMC Awardee)Eric Umar (EPMC Awardee)Mark Adams (EPMC Awardee)Michele Ramsay (EPMC Awardee)Owen Nkoka (EPMC Awardee)Stephen Lawrie (EPMC Awardee)Wisdom Nakanga (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

What is the molecular genetic basis of anxiety in a very-low-income African setting? The Genetics of Anxiety In Malawi (G-AIM) Study
Exploring the genetic and neurological underpinnings of anxiety within the human brain.
ANXIOMICS: Finding the mind, brain and immune pathways to anxiety
Deep phenotyping and developmental trajectory of anxiety in neurodevelopmental disorders
Exploring etiological factors underlying anxiety and its associations with physical health and health-related quality of life.

Original classification

Mental Health Award: Understanding anxiety and trauma

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.